Lizzy241, What makes you think AMRN isn’t fully focused on a timely release of an AG? I’m sure the label has already been decided and ready for production. Management isn’t going to telegraph their plan just to placate us retail investors. They’re at war with generic trolls for the US market. It’s frustrating not knowing what’s going on behind the scenes but I’m confident it includes at least a viable and ready authorized generic strategy. JMHO. Best wishes.
How do you know they're not working on an AG? Silence from the company is maddening, I'll admit that, but revealing your strategy to the generics before you employ it is dumb.